EXplosion!! Eine Frage der Zeit !FEMO.OB - 500 Beiträge pro Seite
eröffnet am 12.08.05 14:42:53 von
neuester Beitrag 23.01.06 16:03:07 von
neuester Beitrag 23.01.06 16:03:07 von
Beiträge: 10
ID: 999.669
ID: 999.669
Aufrufe heute: 0
Gesamt: 736
Gesamt: 736
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| gestern 23:11 | 503 | |
| heute 00:52 | 474 | |
| vor 1 Stunde | 233 | |
| heute 00:16 | 211 | |
| vor 1 Stunde | 201 | |
| vor 56 Minuten | 193 | |
| vor 1 Stunde | 177 | |
| gestern 21:36 | 170 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.610,50 | -0,31 | 213 | |||
| 2. | 3. | 0,7532 | -2,90 | 94 | |||
| 3. | 2. | 3,0500 | +13,17 | 91 | |||
| 4. | 6. | 23,740 | +24,95 | 69 | |||
| 5. | 4. | 176,75 | -1,39 | 65 | |||
| 6. | 5. | 0,1930 | -4,93 | 59 | |||
| 7. | 8. | 1.139,01 | +6,98 | 43 | |||
| 8. | 7. | 2.359,17 | -0,09 | 40 |
Feedback
Mkt cap 850 Kilo
FemOne Completes Financing on 8% Callable Secured Convertible Notes
Tuesday July 5, 6:00 am ET
CARLSBAD, Calif., July 5 /PRNewswire-FirstCall/ -- FemOne, Inc., a publicly-traded Nevada corporation (OTC Bulletin Board: FEMO - News), announced today that it has successfully closed a financing where it will raise gross proceeds of $1,500,000 from the issuance of 8% Callable Secured Convertible Notes (the "Notes"). Proceeds from this financing will be used for business operations and global expansion.
ADVERTISEMENT
The three-year Notes are convertible into shares of the Company`s common stock at a conversion price equal to (1) the average of the three lowest intraday trading prices for the Company`s common stock as quoted by the OTCBB during the 20 days prior to the date of conversion, or (2) $0.40 per share, whichever is lower. In addition to the Notes, the investors received 44,000,000 Stock Purchase Warrants (the "Warrants") to purchase an additional 44,000,000 shares of its common stock at an exercise price of $0.25 per share. The Warrants will have a five (5) year term from the date of issuance.
The shares of common stock underlying the Notes and Warrants will be registered by the Company on a Registration Statement filed with the Securities and Exchange Commission on Form SB-2 within 30 days of a demand for registration by the investors, which demand may not made within ninety (90) days of the closing of this financing.
"The raising of equity financing gives us additional capital to focus on the continued growth of our business and the global expansion of our BIOPRO Technology Division," stated Ray W. Grimm, Jr., the Chief Executive Officer of FemOne, Inc., "There is a strong global interest in our products and we are dedicated to taking advantage of these international opportunities in a focused and efficient manner. This is a very exciting time for our company," Grimm added.
FemOne, Inc. (OTC Bulletin Board: FEMO - News), based in Carlsbad, California is a sales and marketing company with distribution in the United States, Canada, Australia and New Zealand. More information about FemOne and its products can be found on the company`s web sites at www.femone.com or www.bioprotechnology.com, by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company`s operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company`s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement.
These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievement expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "intend," "expects," "plan," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements.
FemOne Completes Financing on 8% Callable Secured Convertible Notes
Tuesday July 5, 6:00 am ET
CARLSBAD, Calif., July 5 /PRNewswire-FirstCall/ -- FemOne, Inc., a publicly-traded Nevada corporation (OTC Bulletin Board: FEMO - News), announced today that it has successfully closed a financing where it will raise gross proceeds of $1,500,000 from the issuance of 8% Callable Secured Convertible Notes (the "Notes"). Proceeds from this financing will be used for business operations and global expansion.
ADVERTISEMENT
The three-year Notes are convertible into shares of the Company`s common stock at a conversion price equal to (1) the average of the three lowest intraday trading prices for the Company`s common stock as quoted by the OTCBB during the 20 days prior to the date of conversion, or (2) $0.40 per share, whichever is lower. In addition to the Notes, the investors received 44,000,000 Stock Purchase Warrants (the "Warrants") to purchase an additional 44,000,000 shares of its common stock at an exercise price of $0.25 per share. The Warrants will have a five (5) year term from the date of issuance.
The shares of common stock underlying the Notes and Warrants will be registered by the Company on a Registration Statement filed with the Securities and Exchange Commission on Form SB-2 within 30 days of a demand for registration by the investors, which demand may not made within ninety (90) days of the closing of this financing.
"The raising of equity financing gives us additional capital to focus on the continued growth of our business and the global expansion of our BIOPRO Technology Division," stated Ray W. Grimm, Jr., the Chief Executive Officer of FemOne, Inc., "There is a strong global interest in our products and we are dedicated to taking advantage of these international opportunities in a focused and efficient manner. This is a very exciting time for our company," Grimm added.
FemOne, Inc. (OTC Bulletin Board: FEMO - News), based in Carlsbad, California is a sales and marketing company with distribution in the United States, Canada, Australia and New Zealand. More information about FemOne and its products can be found on the company`s web sites at www.femone.com or www.bioprotechnology.com, by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company`s operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company`s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement.
These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievement expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "intend," "expects," "plan," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements.
Angespanntes warten auf die Quartalszahlen!
Etwas im Minus
Hier die letzten Zahlen!
Results
Tuesday May 17, 12:26 pm ET
Sales Up 700% From Same Period Last Year
CARLSBAD, Calif., May 17 /PRNewswire-FirstCall/ -- FemOne, Inc. (OTC Bulletin Board: FEMO - News), a publicly held Nevada corporation (the "Company"), reported consolidated sales for the quarter ended March 31, 2005 of $1,752,627, an increase of approximately 700% over the first quarter of 2004. The increase in sales in 2005 is primarily attributed to the growth of FemOne`s technology division, BIOPRO Technology, since the first quarter of 2004.
ADVERTISEMENT
Gross profits for the quarter ended March 31, 2005 were $1,306,319, an increase of 703% over gross profits of $162,586 reported for the first quarter of 2004.
Consolidated net loss attributable to common stockholders for the quarter ended March 31, 2005 was $1,288,245, or ($0.04) per share, compared to a consolidated net loss of $588,477, or ($0.02) per share, for the quarter ended March 31, 2004. The increase in net loss in 2005 was directly attributable to an increase in expenses associated with the Company`s expanded operations and efforts to continue its business growth. Included in the net loss for the 2005 period are other non-cash expenses of approximately $695,000, representing the amortization of charges incurred in connection with the Company`s convertible debt financing.
Operating expenses for the quarter ended March 31, 2005 were $1,843,890, compared to $739,334 for the same period in 2004. The increase in operating expense was due to increases in commission expenses incurred on the increased sales, as well as increases in promotion and marketing expenses and increases in costs incurred as a publicly-reporting company. Operating expenses as a percentage of sales decreased to 105% for the quarter ended March 31, 2005, from 337% for the quarter ended March 31, 2004.
Included in the Company`s consolidated results for the three months ended March 31, 2005 are revenues and expenses from its two controlled subsidiaries, BIOPRO Australasia Pty, Ltd, which operates the Company`s direct sales effort in Australia and New Zealand, and SRA Marketing, Inc., which is responsible for all sales made over the Direct Response Shopping network. Each of these subsidiaries began their operations in the fourth quarter of 2004. Their revenues represent 23% and 16%, respectively, of the Company`s consolidated revenues for the three months ended March 31, 2005.
Commenting on the results, Ray W. Grimm, Jr., the Company`s chief executive officer, stated "To grow our revenues by some 700% within one year is extremely rewarding for us, and a great sign that the marketing efforts and initiatives we have implemented are being received favorably by our distributors and customers. We look forward to keeping this sales momentum and achieving profitability."
The information contained in this press release should be read in connection with the Company`s Annual Report on Form 10-KSB for the year ended December 31, 2004, containing the Report from the Company`s Independent Registered Public Accounting Firm that includes a qualification as to the Company`s ability to continue as a going concern and other information necessary for an understanding of the Company, as well as its Quarterly Report on Form 10-QSB for the period ended March 31, 2005.
About FemOne, Inc.
FemOne, Inc. (OTC Bulletin Board: FEMO - News), based in Carlsbad, California is sales and marketing company with distribution in the United States, Canada, Australia and New Zealand. More information about FemOne and its products can be found on the company`s web sites at www.femone.com or www.bioprotechnology.com, by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company`s operations generally, may differ materially from what is projected in such forward- looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company`s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward- looking statement.
These forward looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievement expressed or implied by such forward looking statements. In some cases, you can identify forward looking statements by terminology such as "may," "will," "should," "could," "intend," "expects," "plan," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements.
FemOne, Inc.
Summary Consolidated Financial Information
Statement of Operations Data: For the three months ended
March 31,
2005 2004
REVENUES
Sales $1,752,627 $219,491
Cost of Sales 446,308 56,905
Gross Profit 1,306,319 162,586
EXPENSES
Order fulfillment costs 882,042 126,642
Sales and marketing 531,033 253,967
General and administrative 430,815 358,725
Total Expenses 1,843,890 739,334
LOSS FROM OPERATIONS (537,571) (576,748)
OTHER INCOME (EXPENSES), net (712,380) (11,729)
LOSS BEFORE MINORITY INTEREST (1,249,951) (588,477)
MINORITY INTEREST IN SUBSIDIARY (38,294) --
NET LOSS $(1,288,245) $(588,477)
NET LOSS PER COMMON SHARE
- Basic and Diluted $(0.04) $(0.02)
WEIGHTED AVERAGE NUMBER OF
COMMON SHARES OUTSTANDING
- Basic and Diluted 36,501,773 26,198,509
Balance Sheet Data:
March 31, December 31,
2005 2004
Cash $496,744 $720,468
Accounts receivable $87,707 $261,888
Inventory $614,880 $370,958
Intangible assets, net $230,908 $239,457
Net working capital $343,886 $882,613
Total assets $1,994,243 $2,309,186
Accounts payable and accrued liabilities $1,026,777 $643,959
Deferred Compensation $76,011 $76,011
Convertible notes payable, net $880,061 $473,336
Notes payable - related parties $650,009 $735,553
Total liabilities $2,632,860 $1,928,859
Minority interest in subsidiaries $81,817 $43,523
Total stockholders deficit $(720,432) $(336,934)
Etwas im Minus
Hier die letzten Zahlen!
Results
Tuesday May 17, 12:26 pm ET
Sales Up 700% From Same Period Last Year
CARLSBAD, Calif., May 17 /PRNewswire-FirstCall/ -- FemOne, Inc. (OTC Bulletin Board: FEMO - News), a publicly held Nevada corporation (the "Company"), reported consolidated sales for the quarter ended March 31, 2005 of $1,752,627, an increase of approximately 700% over the first quarter of 2004. The increase in sales in 2005 is primarily attributed to the growth of FemOne`s technology division, BIOPRO Technology, since the first quarter of 2004.
ADVERTISEMENT
Gross profits for the quarter ended March 31, 2005 were $1,306,319, an increase of 703% over gross profits of $162,586 reported for the first quarter of 2004.
Consolidated net loss attributable to common stockholders for the quarter ended March 31, 2005 was $1,288,245, or ($0.04) per share, compared to a consolidated net loss of $588,477, or ($0.02) per share, for the quarter ended March 31, 2004. The increase in net loss in 2005 was directly attributable to an increase in expenses associated with the Company`s expanded operations and efforts to continue its business growth. Included in the net loss for the 2005 period are other non-cash expenses of approximately $695,000, representing the amortization of charges incurred in connection with the Company`s convertible debt financing.
Operating expenses for the quarter ended March 31, 2005 were $1,843,890, compared to $739,334 for the same period in 2004. The increase in operating expense was due to increases in commission expenses incurred on the increased sales, as well as increases in promotion and marketing expenses and increases in costs incurred as a publicly-reporting company. Operating expenses as a percentage of sales decreased to 105% for the quarter ended March 31, 2005, from 337% for the quarter ended March 31, 2004.
Included in the Company`s consolidated results for the three months ended March 31, 2005 are revenues and expenses from its two controlled subsidiaries, BIOPRO Australasia Pty, Ltd, which operates the Company`s direct sales effort in Australia and New Zealand, and SRA Marketing, Inc., which is responsible for all sales made over the Direct Response Shopping network. Each of these subsidiaries began their operations in the fourth quarter of 2004. Their revenues represent 23% and 16%, respectively, of the Company`s consolidated revenues for the three months ended March 31, 2005.
Commenting on the results, Ray W. Grimm, Jr., the Company`s chief executive officer, stated "To grow our revenues by some 700% within one year is extremely rewarding for us, and a great sign that the marketing efforts and initiatives we have implemented are being received favorably by our distributors and customers. We look forward to keeping this sales momentum and achieving profitability."
The information contained in this press release should be read in connection with the Company`s Annual Report on Form 10-KSB for the year ended December 31, 2004, containing the Report from the Company`s Independent Registered Public Accounting Firm that includes a qualification as to the Company`s ability to continue as a going concern and other information necessary for an understanding of the Company, as well as its Quarterly Report on Form 10-QSB for the period ended March 31, 2005.
About FemOne, Inc.
FemOne, Inc. (OTC Bulletin Board: FEMO - News), based in Carlsbad, California is sales and marketing company with distribution in the United States, Canada, Australia and New Zealand. More information about FemOne and its products can be found on the company`s web sites at www.femone.com or www.bioprotechnology.com, by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company`s operations generally, may differ materially from what is projected in such forward- looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company`s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward- looking statement.
These forward looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievement expressed or implied by such forward looking statements. In some cases, you can identify forward looking statements by terminology such as "may," "will," "should," "could," "intend," "expects," "plan," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements.
FemOne, Inc.
Summary Consolidated Financial Information
Statement of Operations Data: For the three months ended
March 31,
2005 2004
REVENUES
Sales $1,752,627 $219,491
Cost of Sales 446,308 56,905
Gross Profit 1,306,319 162,586
EXPENSES
Order fulfillment costs 882,042 126,642
Sales and marketing 531,033 253,967
General and administrative 430,815 358,725
Total Expenses 1,843,890 739,334
LOSS FROM OPERATIONS (537,571) (576,748)
OTHER INCOME (EXPENSES), net (712,380) (11,729)
LOSS BEFORE MINORITY INTEREST (1,249,951) (588,477)
MINORITY INTEREST IN SUBSIDIARY (38,294) --
NET LOSS $(1,288,245) $(588,477)
NET LOSS PER COMMON SHARE
- Basic and Diluted $(0.04) $(0.02)
WEIGHTED AVERAGE NUMBER OF
COMMON SHARES OUTSTANDING
- Basic and Diluted 36,501,773 26,198,509
Balance Sheet Data:
March 31, December 31,
2005 2004
Cash $496,744 $720,468
Accounts receivable $87,707 $261,888
Inventory $614,880 $370,958
Intangible assets, net $230,908 $239,457
Net working capital $343,886 $882,613
Total assets $1,994,243 $2,309,186
Accounts payable and accrued liabilities $1,026,777 $643,959
Deferred Compensation $76,011 $76,011
Convertible notes payable, net $880,061 $473,336
Notes payable - related parties $650,009 $735,553
Total liabilities $2,632,860 $1,928,859
Minority interest in subsidiaries $81,817 $43,523
Total stockholders deficit $(720,432) $(336,934)
Wenn sie heute nicht kommen, gibts ein E!
Hier Level 2!
Level II Quotebook
Time MMID Size Bid
10:39
Close
TD Waterhouse Capital Markets, Inc.
OTC TRADING
201-369-8830
BULLETIN BOARD
201-369-8889
BULLETIN BOARD
800-500-3905
DEALER/INST SALES
201-369-1000
DEALER/INST SALES
800-369-5775
TDCM
50 0.0113 ↑
07:30
Close
Hill Thompson Magid and Co., Inc.
JERSEY CITY, NJ
201-434-8100
JERSEY CITY, NJ
212-233-2200
NASDAQ TRADING
800-631-3083
ADR TRADING
800-879-9842
CANADIAN EQUITIES
866-235-7016
BANK STOCKS
866-291-6316
CHICAGO, IL
800-999-8073
CHICAGO, IL
312-372-3828
HILL
50 0.011 ↑
07:30
Close
Hudson Securities, Inc.
JERSEY CITY, NJ
201-216-9100
JERSEY CITY, NJ
800-624-0050
JERSEY CITY, NJ
212-227-7733
INSTITUTIONAL SALES
800-419-9187
201-216-0375
COLORADO
888-576-1828
BOCA RATON, FL
800-898-2777
INTERNATIONAL
888-306-1998
561-361-0951
CANADIAN ARB
201-216-1475
HDSN
50 0.011 ↑
13:17
Close
DOMESTIC SECURITIES, INC.
EDISON, NJ - OTC
732-661-0300
MONTVALE, NJ OTC
201-782-0009
MONTVALE, NJ HQ
201-782-0888
DOMS
50 0.011
07:30
Close
Fulcrum Global Partners LLC
OTCBB DESK
212-803-7046
OTCBB BROKER/DEALER
212-803-7070
CANADIAN/FOREIGN DSK
212-803-9026
FLCR
50 0.01 ↑
07:30
Close
Sterne Agee Capital Markets, Inc.
BOCA RATON, FL
561-368-8373
BOCA RATON, FL
800-930-3536
DEALER SALES, FRANK
800-979-4568
SACM
50 0.01 ↑
07:30
Close
J.P. TURNER & COMPANY, L.L.C.
NASDAQ TRADING
404-479-8321
BULLETIN BOARD/PINK
404-479-8321
JPTC
50 0.01 ↑
07:30
Close
WORLD TRADE FINANCIAL CORPORATION
TRADING
619-325-2634
NEW JERSEY
848-628-0080
WORL
50 0.01 ↑
07:30
Close
Tradition Asiel Securities Inc.
NASDAQ
212-791-4770
OTCBB
212-791-5335
TASL
50 0.0085 ↑
07:30
Close
INTL Trading, Inc.
ORLANDO FL
407-741-5399
800-541-1977
OTCBB DESK
800-327-5703
OTCBB DESK
407-741-5394
NEW YORK, NY
212-485-3545
INTL
50 0.001 ↑
07:30
Close
Track ECN (DATA)
MAIN
888-287-8832
TRADING DESK
718-923-3082
DATA
0 0.00
10:30
Close
Archipelago Trading Services, Inc.
TRADING DESK
312-442-7700
GNET
0 0.00
Ask Size MMID Time
0.014 50
Close
UBS Capital Markets L.P.
JERSEY CITY, NJ
N/A
DOMESTIC TRADING
212-514-5140
FOREIGN/ADR TRADING
212-804-3354
OTC BB/PINK TRADING
800-631-3094
DEALER/SALES TRADING
800-213-2923
SCHB
12:35
0.0141 50
Close
TD Waterhouse Capital Markets, Inc.
OTC TRADING
201-369-8830
BULLETIN BOARD
201-369-8889
BULLETIN BOARD
800-500-3905
DEALER/INST SALES
201-369-1000
DEALER/INST SALES
800-369-5775
TDCM
10:39
0.0145 50
Close
Knight Equity Markets, L.P.
NASDAQ TRADING
800-222-4910
NASDAQ TRADING
888-515-0031
BULLETIN BOARD
800-232-3684
DELISTING/BANKRUPTCY
212-336-8656
DELISTING/BANKRUPTCY
212-336-8791
DELISTING/BANKRUPTCY
212-336-8792
INTERNATIONAL
800-762-0271
BROKER/DEALER DESK
888-302-9197
INSTITUTIONAL DESK
800-222-4895
FOREIGN BULLETIN BD
212-336-8841
HELP DESK
888-931-HELP
NITE
12:13
↑ 0.019 50
Close
Sterne Agee Capital Markets, Inc.
BOCA RATON, FL
561-368-8373
BOCA RATON, FL
800-930-3536
DEALER SALES, FRANK
800-979-4568
SACM
07:30
↑ 0.02 50
Close
Hill Thompson Magid and Co., Inc.
JERSEY CITY, NJ
201-434-8100
JERSEY CITY, NJ
212-233-2200
NASDAQ TRADING
800-631-3083
ADR TRADING
800-879-9842
CANADIAN EQUITIES
866-235-7016
BANK STOCKS
866-291-6316
CHICAGO, IL
800-999-8073
CHICAGO, IL
312-372-3828
HILL
07:30
↑ 0.02 50
Close
DOMESTIC SECURITIES, INC.
EDISON, NJ - OTC
732-661-0300
MONTVALE, NJ OTC
201-782-0009
MONTVALE, NJ HQ
201-782-0888
DOMS
13:17
↑ 0.04 50
Close
Hudson Securities, Inc.
JERSEY CITY, NJ
201-216-9100
JERSEY CITY, NJ
800-624-0050
JERSEY CITY, NJ
212-227-7733
INSTITUTIONAL SALES
800-419-9187
201-216-0375
COLORADO
888-576-1828
BOCA RATON, FL
800-898-2777
INTERNATIONAL
888-306-1998
561-361-0951
CANADIAN ARB
201-216-1475
HDSN
07:30
↑ 0.09 50
Close
J.P. TURNER & COMPANY, L.L.C.
NASDAQ TRADING
404-479-8321
BULLETIN BOARD/PINK
404-479-8321
JPTC
07:30
↑ 0.10 50
Close
INTL Trading, Inc.
ORLANDO FL
407-741-5399
800-541-1977
OTCBB DESK
800-327-5703
OTCBB DESK
407-741-5394
NEW YORK, NY
212-485-3545
INTL
07:30
↑ 0.13 50
Close
WORLD TRADE FINANCIAL CORPORATION
TRADING
619-325-2634
NEW JERSEY
848-628-0080
WORL
07:30
↑ 0.15 50
Close
Tradition Asiel Securities Inc.
NASDAQ
212-791-4770
OTCBB
212-791-5335
TASL
07:30
0.15 50
Close
PERSHING TRADING COMPANY, L.P.
JERSEY CITY NJ
201-413-3531
NASDAQ TRADING
800-305-0161
BULLETIN BOARD
201-413-2700
DEALER DESK
201-413-2465
866-880-9410
PERT
10:41
↑ 0.30 50
Close
Fulcrum Global Partners LLC
OTCBB DESK
212-803-7046
OTCBB BROKER/DEALER
212-803-7070
CANADIAN/FOREIGN DSK
212-803-9026
FLCR
07:30
Time & Sales
Price Size Exch Time
0.0115 1440000 OBB 13:08:23
0.0125 50000 OBB 13:07:38
0.0125 100000 OBB 12:50:27
0.013 40000 OBB 12:36:01
0.012 25000 OBB 12:13:42
0.0125 133000 OBB 12:12:54
0.0125 70000 OBB 11:58:54
0.0125 99600 OBB 11:58:08
0.012 99600 OBB 11:58:08
0.012 5000 OBB 11:57:57
0.0118 40000 OBB 11:22:44
0.0118 400000 OBB 11:22:25
0.0118 45000 OBB 11:03:37
0.012 5000 OBB 11:03:13
0.0121 200000 OBB 10:41:38
0.012 400000 OBB 10:39:02
0.0115 170000 OBB 10:30:17
0.0117 9500 OBB 10:29:56
0.0115 100000 OBB 10:29:51
0.0115 5000 OBB 10:29:45
0.0117 500 OBB 10:28:52
0.012 600000 OBB 08/19
0.0125 500000 OBB 08/19
0.013 3000 OBB 08/19
0.0135 50000 OBB 08/19
0.0141 15000 OBB 08/19
0.0141 100000 OBB 08/19
0.0128 330000 OBB 08/19
0.012 1000 OBB 08/19
0.0135 1703 OBB 08/19
Kein Interesse unn warum nicht?
Grüße
Level II Quotebook
Time MMID Size Bid
10:39
Close
TD Waterhouse Capital Markets, Inc.
OTC TRADING
201-369-8830
BULLETIN BOARD
201-369-8889
BULLETIN BOARD
800-500-3905
DEALER/INST SALES
201-369-1000
DEALER/INST SALES
800-369-5775
TDCM
50 0.0113 ↑
07:30
Close
Hill Thompson Magid and Co., Inc.
JERSEY CITY, NJ
201-434-8100
JERSEY CITY, NJ
212-233-2200
NASDAQ TRADING
800-631-3083
ADR TRADING
800-879-9842
CANADIAN EQUITIES
866-235-7016
BANK STOCKS
866-291-6316
CHICAGO, IL
800-999-8073
CHICAGO, IL
312-372-3828
HILL
50 0.011 ↑
07:30
Close
Hudson Securities, Inc.
JERSEY CITY, NJ
201-216-9100
JERSEY CITY, NJ
800-624-0050
JERSEY CITY, NJ
212-227-7733
INSTITUTIONAL SALES
800-419-9187
201-216-0375
COLORADO
888-576-1828
BOCA RATON, FL
800-898-2777
INTERNATIONAL
888-306-1998
561-361-0951
CANADIAN ARB
201-216-1475
HDSN
50 0.011 ↑
13:17
Close
DOMESTIC SECURITIES, INC.
EDISON, NJ - OTC
732-661-0300
MONTVALE, NJ OTC
201-782-0009
MONTVALE, NJ HQ
201-782-0888
DOMS
50 0.011
07:30
Close
Fulcrum Global Partners LLC
OTCBB DESK
212-803-7046
OTCBB BROKER/DEALER
212-803-7070
CANADIAN/FOREIGN DSK
212-803-9026
FLCR
50 0.01 ↑
07:30
Close
Sterne Agee Capital Markets, Inc.
BOCA RATON, FL
561-368-8373
BOCA RATON, FL
800-930-3536
DEALER SALES, FRANK
800-979-4568
SACM
50 0.01 ↑
07:30
Close
J.P. TURNER & COMPANY, L.L.C.
NASDAQ TRADING
404-479-8321
BULLETIN BOARD/PINK
404-479-8321
JPTC
50 0.01 ↑
07:30
Close
WORLD TRADE FINANCIAL CORPORATION
TRADING
619-325-2634
NEW JERSEY
848-628-0080
WORL
50 0.01 ↑
07:30
Close
Tradition Asiel Securities Inc.
NASDAQ
212-791-4770
OTCBB
212-791-5335
TASL
50 0.0085 ↑
07:30
Close
INTL Trading, Inc.
ORLANDO FL
407-741-5399
800-541-1977
OTCBB DESK
800-327-5703
OTCBB DESK
407-741-5394
NEW YORK, NY
212-485-3545
INTL
50 0.001 ↑
07:30
Close
Track ECN (DATA)
MAIN
888-287-8832
TRADING DESK
718-923-3082
DATA
0 0.00
10:30
Close
Archipelago Trading Services, Inc.
TRADING DESK
312-442-7700
GNET
0 0.00
Ask Size MMID Time
0.014 50
Close
UBS Capital Markets L.P.
JERSEY CITY, NJ
N/A
DOMESTIC TRADING
212-514-5140
FOREIGN/ADR TRADING
212-804-3354
OTC BB/PINK TRADING
800-631-3094
DEALER/SALES TRADING
800-213-2923
SCHB
12:35
0.0141 50
Close
TD Waterhouse Capital Markets, Inc.
OTC TRADING
201-369-8830
BULLETIN BOARD
201-369-8889
BULLETIN BOARD
800-500-3905
DEALER/INST SALES
201-369-1000
DEALER/INST SALES
800-369-5775
TDCM
10:39
0.0145 50
Close
Knight Equity Markets, L.P.
NASDAQ TRADING
800-222-4910
NASDAQ TRADING
888-515-0031
BULLETIN BOARD
800-232-3684
DELISTING/BANKRUPTCY
212-336-8656
DELISTING/BANKRUPTCY
212-336-8791
DELISTING/BANKRUPTCY
212-336-8792
INTERNATIONAL
800-762-0271
BROKER/DEALER DESK
888-302-9197
INSTITUTIONAL DESK
800-222-4895
FOREIGN BULLETIN BD
212-336-8841
HELP DESK
888-931-HELP
NITE
12:13
↑ 0.019 50
Close
Sterne Agee Capital Markets, Inc.
BOCA RATON, FL
561-368-8373
BOCA RATON, FL
800-930-3536
DEALER SALES, FRANK
800-979-4568
SACM
07:30
↑ 0.02 50
Close
Hill Thompson Magid and Co., Inc.
JERSEY CITY, NJ
201-434-8100
JERSEY CITY, NJ
212-233-2200
NASDAQ TRADING
800-631-3083
ADR TRADING
800-879-9842
CANADIAN EQUITIES
866-235-7016
BANK STOCKS
866-291-6316
CHICAGO, IL
800-999-8073
CHICAGO, IL
312-372-3828
HILL
07:30
↑ 0.02 50
Close
DOMESTIC SECURITIES, INC.
EDISON, NJ - OTC
732-661-0300
MONTVALE, NJ OTC
201-782-0009
MONTVALE, NJ HQ
201-782-0888
DOMS
13:17
↑ 0.04 50
Close
Hudson Securities, Inc.
JERSEY CITY, NJ
201-216-9100
JERSEY CITY, NJ
800-624-0050
JERSEY CITY, NJ
212-227-7733
INSTITUTIONAL SALES
800-419-9187
201-216-0375
COLORADO
888-576-1828
BOCA RATON, FL
800-898-2777
INTERNATIONAL
888-306-1998
561-361-0951
CANADIAN ARB
201-216-1475
HDSN
07:30
↑ 0.09 50
Close
J.P. TURNER & COMPANY, L.L.C.
NASDAQ TRADING
404-479-8321
BULLETIN BOARD/PINK
404-479-8321
JPTC
07:30
↑ 0.10 50
Close
INTL Trading, Inc.
ORLANDO FL
407-741-5399
800-541-1977
OTCBB DESK
800-327-5703
OTCBB DESK
407-741-5394
NEW YORK, NY
212-485-3545
INTL
07:30
↑ 0.13 50
Close
WORLD TRADE FINANCIAL CORPORATION
TRADING
619-325-2634
NEW JERSEY
848-628-0080
WORL
07:30
↑ 0.15 50
Close
Tradition Asiel Securities Inc.
NASDAQ
212-791-4770
OTCBB
212-791-5335
TASL
07:30
0.15 50
Close
PERSHING TRADING COMPANY, L.P.
JERSEY CITY NJ
201-413-3531
NASDAQ TRADING
800-305-0161
BULLETIN BOARD
201-413-2700
DEALER DESK
201-413-2465
866-880-9410
PERT
10:41
↑ 0.30 50
Close
Fulcrum Global Partners LLC
OTCBB DESK
212-803-7046
OTCBB BROKER/DEALER
212-803-7070
CANADIAN/FOREIGN DSK
212-803-9026
FLCR
07:30
Time & Sales
Price Size Exch Time
0.0115 1440000 OBB 13:08:23
0.0125 50000 OBB 13:07:38
0.0125 100000 OBB 12:50:27
0.013 40000 OBB 12:36:01
0.012 25000 OBB 12:13:42
0.0125 133000 OBB 12:12:54
0.0125 70000 OBB 11:58:54
0.0125 99600 OBB 11:58:08
0.012 99600 OBB 11:58:08
0.012 5000 OBB 11:57:57
0.0118 40000 OBB 11:22:44
0.0118 400000 OBB 11:22:25
0.0118 45000 OBB 11:03:37
0.012 5000 OBB 11:03:13
0.0121 200000 OBB 10:41:38
0.012 400000 OBB 10:39:02
0.0115 170000 OBB 10:30:17
0.0117 9500 OBB 10:29:56
0.0115 100000 OBB 10:29:51
0.0115 5000 OBB 10:29:45
0.0117 500 OBB 10:28:52
0.012 600000 OBB 08/19
0.0125 500000 OBB 08/19
0.013 3000 OBB 08/19
0.0135 50000 OBB 08/19
0.0141 15000 OBB 08/19
0.0141 100000 OBB 08/19
0.0128 330000 OBB 08/19
0.012 1000 OBB 08/19
0.0135 1703 OBB 08/19
Kein Interesse unn warum nicht?
Grüße
Die Zahlen
FemOne Announces Second Quarter 2005 Earnings Results
Monday August 22, 5:28 pm ET
Sales Up 600%, Gross Profits Up 680% From Same Period Last Year
CARLSBAD, Calif., Aug. 22 /PRNewswire-FirstCall/ -- FemOne, Inc. (OTC Bulletin Board: FEMO - News), a publicly held Nevada corporation (the "Company"), reported consolidated sales for the second quarter of 2005.
ADVERTISEMENT
click here
FemOne reported consolidated net sales of $1,867,076 for the three months ended June 30, 2005, an increase of approximately 600%, from $262,540 for the three months ended June 30, 2004. Consolidated net sales for the six months ended June 30, 2005 increased to $3,619,705 from $482,032 for the same period in 2004. The increase in sales in the 2005 periods of approximately 650% is primarily attributed to the continued growth of FemOne`s technology division, BIOPRO Technology.
Gross profits for the three months ended June 30, 2005 increased to $1,456,228 from $186,617 during the three months ended June 30, 2004. The increase in gross profits of approximately 680% is directly attributable to the overall increase in net sales in 2005 and increases in gross margins is primarily due to increased profits from Direct Sales of approximately 640% attributed to the growth in our BIOPRO Technology division in the U.S., Australia and New Zealand. Also contributing to the increase in gross profits during the 2005 period are gross profits from Direct Response Television Shopping of approximately $222,240 from our subsidiary SRA Marketing. Gross profits for the six months ended June 30, 2005 increased to $2,762,549 from $349,805 over the same period in 2004.
Consolidated net loss attributable to common stockholders for the three months ended June 30, 2005 was $762,794, or ($0.01) per share, compared to a consolidated net loss of $511,305, or ($0.02) per share, for the three months ended June 30, 2004. Consolidated net loss attributable to stockholders for the six months ended June 30, 2005 was $2,051,041, or ($0.04) per share, compared to a consolidated net loss of $1,099,182, or ($0.04), per share for the same period in 2004. The increase in net loss in 2005 over 2004 was directly attributable to an increase in expenses associated with the Company`s expanded operations and efforts to continue its business growth. Included in the net loss for the three and six month periods ended June 30, 2005 are expenses of approximately $450,000 and $1,220,000, respectively, representing non-cash amortization expense related to the Company`s convertible debt financing.
Operating expenses for the three months ended June 30, 2005 were $1,732,128, compared to $680,060 for the same period in 2004. Operating expenses for the six months ended June 30, 2005 were $3,576,020, compared to $1,419,396 for the same period in 2004. Operating expenses as a percentage of sales for the three and six months ended June 30, 2005 decreased to 93% and 99%, respectively, compared to 259% and 294%, respectively, in the 2004 periods. The significant decrease of operating expenses as a percentage of sales has been predominantly a result of the 650% increase in sales. The increase in operating expenses in the 2005 periods was the result of increases in commission expenses incurred on the increased sales, as well as increases in promotion and marketing expenses, and our expanded operations in Australia and New Zealand.
Included in the Company`s consolidated results for the three and six months ended June 30, 2005 are revenues and expenses from its two controlled subsidiaries, BIOPRO Australasia Pty, Ltd, which operates the Company`s direct sales effort in Australia and New Zealand, and SRA Marketing, Inc., which is responsible for all sales made over the Direct Response Shopping network. Each of these subsidiaries began their operations in the fourth quarter of 2004. Revenues during the three and six months ended June 20, 2005, from BIOPRO Australasia Pty, Ltd., represented 25% and 26%, respectively, of the Company`s consolidated revenues for those periods. Revenues from SRA Marketing during the three and six months ended June 30, 2005, represent 7% and 11%, respectively, of the Company`s consolidated revenues for those periods.
Commenting on the results, Ray W. Grimm, Jr., the Company`s chief executive officer, stated "We continue to see the rewards of our marketing efforts with our significant revenue growth over prior periods. We will continue to focus our efforts on building our sales momentum, expanding our market presence, and achieving profitability."
The information contained in this press release should be read in connection with the Company`s Annual Report on Form 10-KSB for the year ended December 31, 2004, containing the Report from the Company`s Independent Registered Public Accounting Firm that includes a qualification as to the Company`s ability to continue as a going concern and other information necessary for an understanding of the Company, as well as its Quarterly Report on Form 10-QSB for the period ended June 30, 2005.
About FemOne, Inc.
FemOne, Inc. (OTC Bulletin Board: FEMO - News), based in Carlsbad, California is sales and marketing company with distribution in the United States, Canada, Australia and New Zealand. More information about FemOne and its products can be found on the company`s web sites at www.femone.com or www.bioprotechnology.com, by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company`s operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company`s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement.
These forward looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievement expressed or implied by such forward looking statements. In some cases, you can identify forward looking statements by terminology such as "may," "will," "should," "could," "intend," "expects," "plan," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements.
FemOne, Inc.
Summary Financial Information
Statement of
Operations Data: For the Three Months Ended For the Six Months Ended
June 30, June 30,
2005 2004 2005 2004
REVENUES
Sales $1,867,076 $262,540 $3,619,705 $482,032
Cost of Sales 410,848 75,923 857,156 132,227
Gross Profit 1,456,228 186,617 2,762,549 349,805
EXPENSES
Order fulfillment
costs 892,884 187,172 1,774,926 313,815
Sales and
marketing 475,966 121,303 1,023,051 375,270
General and
administrative 363,278 371,585 778,043 730,311
Total Expenses 1,732,128 680,060 3,576,020 1,419,396
LOSS FROM OPERATIONS (275,900) (493,443) (813,471) (1,069,591)
OTHER INCOME
(EXPENSES), net
LOSS BEFORE
MINORITY INTEREST (746,881) (511,305) (1,996,834) (1,099,182)
MINORITY INTEREST
IN SUBSIDIARY (15,913) -- (54,207) --
NET LOSS $(762,794) $(511,305) $(2,051,041) $(1,099,182)
NET LOSS
PER COMMON
SHARE - Basic
and Diluted $(0.01) $ (0.02) $(0.04) $(0.04)
WEIGHTED AVERAGE
NUMBER OF COMMON
SHARES
OUTSTANDING -
Basic and
Diluted 58,973,112 26,383,509 54,973,112 26,324,009
Balance Sheet Data:
June 30, December 31,
2005 2004
Cash $1,302,190 $720,468
Accounts receivable $190,048 $261,888
Inventory $658,475 $370,958
Intangible assets, net $222,320 $239,497
Net working capital $1,303,419 $882,613
Total assets $2,976,287 $2,309,186
Accounts payable and accrued liabilities $922,673 $643,959
Deferred Compensation $60,456 $76,011
Convertible notes payable, net $996,223 $473,336
Notes payable - related parties $300,009 $735,583
Total liabilities $2,279,361 $1,928,859
Minority interest in subsidiaries $97,730 $43,523
Total stockholders equity $599,196 $336,804
FemOne Announces Second Quarter 2005 Earnings Results
Monday August 22, 5:28 pm ET
Sales Up 600%, Gross Profits Up 680% From Same Period Last Year
CARLSBAD, Calif., Aug. 22 /PRNewswire-FirstCall/ -- FemOne, Inc. (OTC Bulletin Board: FEMO - News), a publicly held Nevada corporation (the "Company"), reported consolidated sales for the second quarter of 2005.
ADVERTISEMENT
click here
FemOne reported consolidated net sales of $1,867,076 for the three months ended June 30, 2005, an increase of approximately 600%, from $262,540 for the three months ended June 30, 2004. Consolidated net sales for the six months ended June 30, 2005 increased to $3,619,705 from $482,032 for the same period in 2004. The increase in sales in the 2005 periods of approximately 650% is primarily attributed to the continued growth of FemOne`s technology division, BIOPRO Technology.
Gross profits for the three months ended June 30, 2005 increased to $1,456,228 from $186,617 during the three months ended June 30, 2004. The increase in gross profits of approximately 680% is directly attributable to the overall increase in net sales in 2005 and increases in gross margins is primarily due to increased profits from Direct Sales of approximately 640% attributed to the growth in our BIOPRO Technology division in the U.S., Australia and New Zealand. Also contributing to the increase in gross profits during the 2005 period are gross profits from Direct Response Television Shopping of approximately $222,240 from our subsidiary SRA Marketing. Gross profits for the six months ended June 30, 2005 increased to $2,762,549 from $349,805 over the same period in 2004.
Consolidated net loss attributable to common stockholders for the three months ended June 30, 2005 was $762,794, or ($0.01) per share, compared to a consolidated net loss of $511,305, or ($0.02) per share, for the three months ended June 30, 2004. Consolidated net loss attributable to stockholders for the six months ended June 30, 2005 was $2,051,041, or ($0.04) per share, compared to a consolidated net loss of $1,099,182, or ($0.04), per share for the same period in 2004. The increase in net loss in 2005 over 2004 was directly attributable to an increase in expenses associated with the Company`s expanded operations and efforts to continue its business growth. Included in the net loss for the three and six month periods ended June 30, 2005 are expenses of approximately $450,000 and $1,220,000, respectively, representing non-cash amortization expense related to the Company`s convertible debt financing.
Operating expenses for the three months ended June 30, 2005 were $1,732,128, compared to $680,060 for the same period in 2004. Operating expenses for the six months ended June 30, 2005 were $3,576,020, compared to $1,419,396 for the same period in 2004. Operating expenses as a percentage of sales for the three and six months ended June 30, 2005 decreased to 93% and 99%, respectively, compared to 259% and 294%, respectively, in the 2004 periods. The significant decrease of operating expenses as a percentage of sales has been predominantly a result of the 650% increase in sales. The increase in operating expenses in the 2005 periods was the result of increases in commission expenses incurred on the increased sales, as well as increases in promotion and marketing expenses, and our expanded operations in Australia and New Zealand.
Included in the Company`s consolidated results for the three and six months ended June 30, 2005 are revenues and expenses from its two controlled subsidiaries, BIOPRO Australasia Pty, Ltd, which operates the Company`s direct sales effort in Australia and New Zealand, and SRA Marketing, Inc., which is responsible for all sales made over the Direct Response Shopping network. Each of these subsidiaries began their operations in the fourth quarter of 2004. Revenues during the three and six months ended June 20, 2005, from BIOPRO Australasia Pty, Ltd., represented 25% and 26%, respectively, of the Company`s consolidated revenues for those periods. Revenues from SRA Marketing during the three and six months ended June 30, 2005, represent 7% and 11%, respectively, of the Company`s consolidated revenues for those periods.
Commenting on the results, Ray W. Grimm, Jr., the Company`s chief executive officer, stated "We continue to see the rewards of our marketing efforts with our significant revenue growth over prior periods. We will continue to focus our efforts on building our sales momentum, expanding our market presence, and achieving profitability."
The information contained in this press release should be read in connection with the Company`s Annual Report on Form 10-KSB for the year ended December 31, 2004, containing the Report from the Company`s Independent Registered Public Accounting Firm that includes a qualification as to the Company`s ability to continue as a going concern and other information necessary for an understanding of the Company, as well as its Quarterly Report on Form 10-QSB for the period ended June 30, 2005.
About FemOne, Inc.
FemOne, Inc. (OTC Bulletin Board: FEMO - News), based in Carlsbad, California is sales and marketing company with distribution in the United States, Canada, Australia and New Zealand. More information about FemOne and its products can be found on the company`s web sites at www.femone.com or www.bioprotechnology.com, by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company`s operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company`s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement.
These forward looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievement expressed or implied by such forward looking statements. In some cases, you can identify forward looking statements by terminology such as "may," "will," "should," "could," "intend," "expects," "plan," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements.
FemOne, Inc.
Summary Financial Information
Statement of
Operations Data: For the Three Months Ended For the Six Months Ended
June 30, June 30,
2005 2004 2005 2004
REVENUES
Sales $1,867,076 $262,540 $3,619,705 $482,032
Cost of Sales 410,848 75,923 857,156 132,227
Gross Profit 1,456,228 186,617 2,762,549 349,805
EXPENSES
Order fulfillment
costs 892,884 187,172 1,774,926 313,815
Sales and
marketing 475,966 121,303 1,023,051 375,270
General and
administrative 363,278 371,585 778,043 730,311
Total Expenses 1,732,128 680,060 3,576,020 1,419,396
LOSS FROM OPERATIONS (275,900) (493,443) (813,471) (1,069,591)
OTHER INCOME
(EXPENSES), net
LOSS BEFORE
MINORITY INTEREST (746,881) (511,305) (1,996,834) (1,099,182)
MINORITY INTEREST
IN SUBSIDIARY (15,913) -- (54,207) --
NET LOSS $(762,794) $(511,305) $(2,051,041) $(1,099,182)
NET LOSS
PER COMMON
SHARE - Basic
and Diluted $(0.01) $ (0.02) $(0.04) $(0.04)
WEIGHTED AVERAGE
NUMBER OF COMMON
SHARES
OUTSTANDING -
Basic and
Diluted 58,973,112 26,383,509 54,973,112 26,324,009
Balance Sheet Data:
June 30, December 31,
2005 2004
Cash $1,302,190 $720,468
Accounts receivable $190,048 $261,888
Inventory $658,475 $370,958
Intangible assets, net $222,320 $239,497
Net working capital $1,303,419 $882,613
Total assets $2,976,287 $2,309,186
Accounts payable and accrued liabilities $922,673 $643,959
Deferred Compensation $60,456 $76,011
Convertible notes payable, net $996,223 $473,336
Notes payable - related parties $300,009 $735,583
Total liabilities $2,279,361 $1,928,859
Minority interest in subsidiaries $97,730 $43,523
Total stockholders equity $599,196 $336,804
Trading Spotlight
Zahlen scheinen gut anzukommen!
1,3 Mill. Cash!!!
Grüße
1,3 Mill. Cash!!!
Grüße
FemOne`s BIOPRO Division Expands Sales Force Into the Philippines
Thursday September 1, 12:00 pm ET
CARLSBAD, Calif., Sept. 1 /PRNewswire-FirstCall/ -- BIOPRO Technology, a division of FemOne, Inc., a publicly held Nevada Corporation (OTC Bulletin Board: FEMO - News), announced today that it plans to open for business in the Philippines with an office and distribution center in Pasig City. Mr. Juan Rodulfa has been appointed Managing Director and will oversee all sales and operations.
ADVERTISEMENT
"We are pleased to announce this expansion and opening of BIOPRO Philippines," stated Chairman and Chief Executive Officer, Ray W. Grimm, Jr. "Mr. Rodulfa is a highly experienced and seasoned network marketing professional, well qualified to manage the Philippines operation. He has begun recruiting industry leaders to assist in getting us off to a fast start on our anticipated launch date of October 1, 2005."
BIOPRO Technology markets and sells Bioenergetics products through direct sales in the United States, Canada, Australia, New Zealand, and soon in the Philippines. BIOPRO products are developed using its proprietary Energy Resonance Technology ("ERT"). Among BIOPRO`s product line are devices that assist in harmonizing the effects of Electromagnetic radiation emitted from cell phones and other appliances. For more information on BIOPRO Technology, visit www.bioprotechnology.com.
About FemOne, Inc.
FemOne, Inc. (OTC Bulletin Board: FEMO - News), based in Carlsbad, California is sales and marketing company with distribution in the United States, Canada, Australia, New Zealand, and soon in the Philippines. More information about FemOne and its products can be found on the company`s web sites at www.femone.com or www.bioprotechnology.com, by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company`s operations generally, may differ materially from what is projected in such forward- looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company`s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward- looking statement.
Thursday September 1, 12:00 pm ET
CARLSBAD, Calif., Sept. 1 /PRNewswire-FirstCall/ -- BIOPRO Technology, a division of FemOne, Inc., a publicly held Nevada Corporation (OTC Bulletin Board: FEMO - News), announced today that it plans to open for business in the Philippines with an office and distribution center in Pasig City. Mr. Juan Rodulfa has been appointed Managing Director and will oversee all sales and operations.
ADVERTISEMENT
"We are pleased to announce this expansion and opening of BIOPRO Philippines," stated Chairman and Chief Executive Officer, Ray W. Grimm, Jr. "Mr. Rodulfa is a highly experienced and seasoned network marketing professional, well qualified to manage the Philippines operation. He has begun recruiting industry leaders to assist in getting us off to a fast start on our anticipated launch date of October 1, 2005."
BIOPRO Technology markets and sells Bioenergetics products through direct sales in the United States, Canada, Australia, New Zealand, and soon in the Philippines. BIOPRO products are developed using its proprietary Energy Resonance Technology ("ERT"). Among BIOPRO`s product line are devices that assist in harmonizing the effects of Electromagnetic radiation emitted from cell phones and other appliances. For more information on BIOPRO Technology, visit www.bioprotechnology.com.
About FemOne, Inc.
FemOne, Inc. (OTC Bulletin Board: FEMO - News), based in Carlsbad, California is sales and marketing company with distribution in the United States, Canada, Australia, New Zealand, and soon in the Philippines. More information about FemOne and its products can be found on the company`s web sites at www.femone.com or www.bioprotechnology.com, by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company`s operations generally, may differ materially from what is projected in such forward- looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company`s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward- looking statement.
Alles wird gut!!
Bald ist hier richtig Bewegung, der Wert ist definitiv unterbewertet.Nicht das es dann heißt hättet Ihr mal was gesagt!
Grüße
Grüße
Geht doch!
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 213 | ||
| 94 | ||
| 91 | ||
| 69 | ||
| 65 | ||
| 59 | ||
| 43 | ||
| 40 | ||
| 37 | ||
| 28 |
| Wertpapier | Beiträge | |
|---|---|---|
| 25 | ||
| 25 | ||
| 22 | ||
| 21 | ||
| 20 | ||
| 20 | ||
| 19 | ||
| 18 | ||
| 16 | ||
| 15 |
